{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:05:48Z","timestamp":1756425948423,"version":"3.44.0"},"reference-count":15,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","award":["ERP-2023-13609"],"award-info":[{"award-number":["ERP-2023-13609"]}],"id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Heart failure with a reduced ejection fraction (HFrEF) is a common and serious condition often associated with atrial fibrillation (AF) and ventricular arrhythmias, leading to poor outcomes such as rehospitalizations and death. Detecting asymptomatic arrhythmias remains challenging, as traditional monitoring methods like 12-lead electrocardiograms (ECGs) or Holter ECGs are insufficient for continuous surveillance. This study aims to evaluate the utility of continuous arrhythmia monitoring using an implantable loop recorder (ILR) to detect asymptomatic arrhythmias in HFrEF patients, particularly for AF and ventricular tachycardia (VT).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and analysis<\/jats:title>\n<jats:p>This is a single-center, non-randomized exploratory study. Thirty-five patients with HFrEF (LVEF\u2009\u2264\u200940%) and no history of AF will receive ILR implants. Primary endpoints include the detection of new-onset AF lasting at least 6 minutes and sustained or non-sustained VT. Secondary endpoints include the identification of bradycardia, pauses, and other arrhythmias, along with cardiovascular outcomes such as death and hospitalization. Additionally, secondary endpoints will include arrhythmia treatments, including anticoagulation therapy, catheter ablation, and implant of therapy devices. Data will be collected via remote monitoring through the Medtronic CareLink system, with event rates estimated using Kaplan-Meier methods. Data collection will span three years, with analyses conducted in the first and third years.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The LINQ2-HF trial is designed to detect new-onset AF and VT in HFrEF patients using ILR, with the aim of informing future strategies for arrhythmia management in this population.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Name of the registry<\/jats:title>\n<jats:p>Japan Registry of Clinical Trials (jRCT).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Trial registry number<\/jats:title>\n<jats:p>jRCTs032240593<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec006\">\n<jats:title>Registration data<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCTs032240593\" xlink:type=\"simple\">https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCTs032240593<\/jats:ext-link><\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0321604","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:30:47Z","timestamp":1756402247000},"page":"e0321604","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2695-1106","authenticated-orcid":true,"given":"Ryo","family":"Tateishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0230-0934","authenticated-orcid":true,"given":"Shinsuke","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Yamao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Omori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-9278","authenticated-orcid":true,"given":"Iwanari","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-2431","authenticated-orcid":true,"given":"Yuji","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Yamakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0089-9779","authenticated-orcid":true,"given":"Kentaro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Ochida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Umemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masateru","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Yonetsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Maejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"3","key":"pone.0321604.ref001","first-page":"489","article-title":"Impending epidemic: future projection of heart failure in Japan to the year 2055","volume":"72","author":"Y Okura","year":"2008","journal-title":"Circ J"},{"issue":"27","key":"pone.0321604.ref002","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"P Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"20","key":"pone.0321604.ref003","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes","volume":"70","author":"KS Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"pone.0321604.ref004","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"pone.0321604.ref005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1253\/circj.CJ-16-0759","article-title":"Prognostic Impact of Atrial Fibrillation and New Risk Score of Its Onset in Patients at High Risk of Heart Failure- A Report From the CHART-2 Study","volume":"81","author":"T Yamauchi","year":"2017","journal-title":"Circ J"},{"issue":"10","key":"pone.0321604.ref006","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"LG Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"pone.0321604.ref007","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"EC Stecker","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"pone.0321604.ref008","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"SM Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"pone.0321604.ref009","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.119.044407","article-title":"Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights From Patients at Risk Monitored Long Term With an Implantable Loop Recorder","volume":"141","author":"SZ Diederichsen","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"pone.0321604.ref010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of Monitoring Strategy on Assessment of Ablation Success and Postablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design","volume":"145","author":"M Aguilar","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"pone.0321604.ref011","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12733","article-title":"Diagnostic value of implantable loop recorder in patients undergoing cryoballoon ablation of atrial fibrillation","volume":"25","author":"A Kusiak","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"14","key":"pone.0321604.ref012","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control Therapy in Patients with Atrial Fibrillation","volume":"383","author":"P Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0321604.ref013","unstructured":"National Cancer Center Japan. n.d. Available from: https:\/\/www.ncc.go.jp\/jp\/information\/pr_release\/2020\/0317\/ncc_press_release_20200317_00.pdf"},{"issue":"6","key":"pone.0321604.ref014","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","article-title":"Heart failure and atrial fibrillation, like fire and fury","volume":"7","author":"MA Carlisle","year":"2019","journal-title":"JACC Heart Failure"},{"issue":"5","key":"pone.0321604.ref015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter Ablation for Atrial Fibrillation with Heart Failure","volume":"378","author":"NF Marrouche","year":"2018","journal-title":"N Engl J Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:30:51Z","timestamp":1756402251000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321604"}},"subtitle":[],"editor":[{"given":"Amirmohammad","family":"Khalaji","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321604","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}